• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉介入治疗后,缝合介导闭合装置与传统手动压迫在成本和安全性方面的比较。

Comparison of costs and safety of a suture-mediated closure device with conventional manual compression after coronary artery interventions.

作者信息

Rickli Hans, Unterweger Martin, Sütsch Gabor, Brunner-La Rocca Hans Peter, Sagmeister Markus, Ammann Peter, Amann Franz W

机构信息

Department of Clinical Medicine, Division of Cardiology, Kantonsspital, St. Gallen, Switzerland.

出版信息

Catheter Cardiovasc Interv. 2002 Nov;57(3):297-302. doi: 10.1002/ccd.10294.

DOI:10.1002/ccd.10294
PMID:12410501
Abstract

The aim of this study was to assess costs and safety of immediate femoral sheath removal and closure with a suture-mediated closure device (Perclose, Menlo Park, CA) in patients undergoing elective (PCI). A total of 193 patients was prospectively randomized to immediate arterial sheath removal and access site closure with a suture-mediated closure device (SMC; n = 96) or sheath removal 4 hr after PCI followed by manual compression (MC; n = 97). In the SMC group, patients were ambulated 4 hr after elective PCI if hemostasis was achieved. In the MC group, patients were ambulated the day after the procedure. In addition to safety, total direct costs including physician and nursing time, infrastructure, and the device were assessed in both groups. Total direct costs were significantly (all P < 0.001) lower in the SMC group. Successful hemostasis without major complication was achieved in all patients. The time to achieve hemostasis was significantly shorter in the SMC group (7.1 +/- 3.4 vs. 22.9 +/- 14.0 min; P < 0.01) and 85% of SMC patients were ambulated on the day of intervention. Suture-mediated closure allows a reduction in hospitalization time, leading to significant cost savings due to decreased personnel and infrastructural demands. In addition, the use of SMC is safe and convenient to the patients.

摘要

本研究的目的是评估在接受择期经皮冠状动脉介入治疗(PCI)的患者中,使用缝线介导闭合装置(Perclose,位于加利福尼亚州门洛帕克)立即拔除股动脉鞘并闭合穿刺部位的成本和安全性。总共193例患者被前瞻性随机分为两组,一组使用缝线介导闭合装置(SMC;n = 96)立即拔除动脉鞘并闭合穿刺部位,另一组在PCI术后4小时拔除鞘管,随后进行手工压迫(MC;n = 97)。在SMC组中,如果实现止血,择期PCI术后4小时让患者下床活动。在MC组中,患者在术后第二天下床活动。除了安全性评估外,还对两组包括医生和护理时间、基础设施以及装置在内的总直接成本进行了评估。SMC组的总直接成本显著更低(所有P < 0.001)。所有患者均成功止血且无 major complication。SMC组实现止血的时间显著更短(7.1 +/- 3.4分钟 vs. 22.9 +/- 14.0分钟;P < 0.01),85%的SMC组患者在干预当天即可下床活动。缝线介导闭合可缩短住院时间,由于人员和基础设施需求减少而显著节省成本。此外,使用SMC对患者来说安全且方便。

相似文献

1
Comparison of costs and safety of a suture-mediated closure device with conventional manual compression after coronary artery interventions.冠状动脉介入治疗后,缝合介导闭合装置与传统手动压迫在成本和安全性方面的比较。
Catheter Cardiovasc Interv. 2002 Nov;57(3):297-302. doi: 10.1002/ccd.10294.
2
The safety and efficacy of "pre-closure" utilizing the Closer suture-mediated vascular closure device for achievement of hemostasis in patients following coronary interventions: results of the second Perclose Accelerated Ambulation and Discharge (PARADISE II) Trial.使用Closer缝线介导的血管闭合装置进行“预闭合”以实现冠状动脉介入治疗患者止血的安全性和有效性:第二项Perclose加速活动与出院(PARADISE II)试验的结果
J Invasive Cardiol. 2005 Jan;17(1):30-3.
3
Clinical effectiveness of the Prostar XL suture-mediated percutaneous vascular closure device following PCI: results of the Perclose AcceleRated Ambulation and DISchargE (PARADISE) Trial.PCI术后使用Prostar XL缝线介导的经皮血管闭合装置的临床有效性:Perclose加速步行与出院(PARADISE)试验结果
J Invasive Cardiol. 2003 May;15(5):251-6.
4
Novel femoral artery puncture closure device in patients undergoing interventional and diagnostic cardiac procedures.用于接受介入性和诊断性心脏手术患者的新型股动脉穿刺闭合装置。
J Invasive Cardiol. 2002 Jan;14(1):9-12.
5
On-site immediate removal of intraortic balloon pump after high-risk percutaneous intervention with a 6 F closure suture device with the "preclosure" technique.在高危经皮介入术后,采用“预闭合”技术,使用6F闭合缝合装置在现场即时移除主动脉内球囊泵。
Catheter Cardiovasc Interv. 2007 Oct 1;70(4):538-40. doi: 10.1002/ccd.21137.
6
Can the use of suture-mediated closure devices save the American health care system?
Catheter Cardiovasc Interv. 2002 Nov;57(3):303-4. doi: 10.1002/ccd.10318.
7
A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial.一项比较压迫止血、Perclose Proglide血管缝合器和Angio-Seal VIP血管闭合装置用于经皮冠状动脉介入治疗后动脉闭合的随机试验:CAP试验。
Catheter Cardiovasc Interv. 2008 Jan 1;71(1):1-5. doi: 10.1002/ccd.21333.
8
Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention.经皮冠状动脉介入治疗后,动脉闭合装置与外部压迫装置相比的患者耐受性及资源利用情况。
Catheter Cardiovasc Interv. 2004 Oct;63(2):166-70. doi: 10.1002/ccd.20161.
9
Percutaneous suture-mediated closure of femoral access sites deployed through the procedure sheath: initial clinical experience with a novel vascular closure device.经皮缝线介导闭合通过手术鞘置入的股动脉穿刺部位:一种新型血管闭合装置的初步临床经验
Catheter Cardiovasc Interv. 2003 Mar;58(3):313-21. doi: 10.1002/ccd.10472.
10
Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial.封堵装置对高局部风险患者并发症发生率的影响:一项随机多中心试验的结果
Catheter Cardiovasc Interv. 2003 Mar;58(3):285-91. doi: 10.1002/ccd.10431.

引用本文的文献

1
Safety and effectiveness of single ProStyle™/ProGlide™ for aortic endovascular procedures: single-style study.单根ProStyle™/ProGlide™用于主动脉血管内手术的安全性和有效性:单式研究
Front Cardiovasc Med. 2025 Jul 3;12:1559131. doi: 10.3389/fcvm.2025.1559131. eCollection 2025.
2
Femoral Artery Closure Devices vs Manual Compression During Cardiac Catheterization and Percutaneous Coronary Intervention.心脏导管插入术和经皮冠状动脉介入治疗期间股动脉闭合装置与手动压迫的比较
J Soc Cardiovasc Angiogr Interv. 2022 Jun 29;1(5):100370. doi: 10.1016/j.jscai.2022.100370. eCollection 2022 Sep-Oct.
3
Best practices for vascular arterial access and closure: a contemporary guide for the cardiac catheterization laboratory.
血管动脉通路与闭合的最佳实践:心脏导管实验室当代指南
Front Cardiovasc Med. 2024 Mar 14;11:1349480. doi: 10.3389/fcvm.2024.1349480. eCollection 2024.
4
[Not Available].[无可用内容]
J Vasc Bras. 2017 Apr-Jun;16(2):98-103. doi: 10.1590/1677-5449.000717.
5
Femoral arterial closure using ProGlide® is more efficacious and cost-effective when ambulating early following cardiac catheterization.在心脏导管插入术后早期活动时,使用ProGlide®进行股动脉闭合更有效且更具成本效益。
Int J Cardiol Heart Vasc. 2016 Oct 11;13:6-13. doi: 10.1016/j.ijcha.2016.09.002. eCollection 2016 Dec.
6
Short-Term Safety and Efficacy of Femoral Vascular Closure after Percutaneous Coronary Intervention with Combination of the Boomerang(TM) Device and Intravenous Protamine Sulfate.使用回飞镖(Boomerang™)装置与静脉注射硫酸鱼精蛋白联合进行经皮冠状动脉介入治疗后股血管闭合的短期安全性和有效性
Acta Cardiol Sin. 2013 Nov;29(6):531-8.
7
Vascular closure devices for femoral arterial puncture site haemostasis.用于股动脉穿刺部位止血的血管闭合装置。
Cochrane Database Syst Rev. 2016 Mar 7;3(3):CD009541. doi: 10.1002/14651858.CD009541.pub2.
8
Early decision-analytic modeling - a case study on vascular closure devices.早期决策分析模型——血管闭合装置的案例研究
BMC Health Serv Res. 2015 Oct 27;15:486. doi: 10.1186/s12913-015-1118-3.
9
Network Meta-analysis of Randomized Trials on the Safety of Vascular Closure Devices for Femoral Arterial Puncture Site Haemostasis.用于股动脉穿刺部位止血的血管闭合装置安全性的随机试验网络荟萃分析
Sci Rep. 2015 Sep 8;5:13761. doi: 10.1038/srep13761.
10
Incidence of delayed angiographic femoral artery complications using the EXOSEAL vascular closure device.使用EXOSEAL血管闭合装置后延迟性血管造影股动脉并发症的发生率。
Interv Neuroradiol. 2015 Jun;21(3):401-6. doi: 10.1177/1591019915581776. Epub 2015 May 26.